Table 3.
Total (n = 914) | T1DM (n = 210) | T2DM (n = 503) | Non-DM (n = 148) | p value | |
---|---|---|---|---|---|
ERT | 546 (60%) | 108 (51%) | 314 (62%) | 124 (84%) | <.001 |
Hospitalization | 276 (30%) | 41 (20%) | 166 (33%) | 69 (47%) | <.001 |
Duration of hospital stay (SD), days | 4.1 (5.8) | 5.9 (10.6) | 3.5 (3.9) | 4.2 (5.2) | .065 |
Endocrinology consultation | 399 (44%) | 146 (69%) | 239 (47%) | 14 (10%) | <.001 |
Pancreas transplant | 12 (1%) | 12 (6%) | 0 | NA | <.001 |
Mortality | 240 (26%) | 33 (16%) | 172 (34%) | 35 (24%) | <.001 |
Median duration to death in those patients who died, years | 1.2 (IQR 0.2–2.7) | 1.8 (IQR 0.8–4.0) | 1.3 (IQR 0.2–2.7) | 0.1 (IQR 0.01–2.1) | .01 |
Known causes of mortality | 172/240 (72%) | 25/33 (76%) | 120/172 (70%) | 27/35 (77%) | NA |
Autopsy confirmation of mortality causes | 121/172 (70%) | 19/25 (76%) | 87/120 (73%) | 15/27 (56%) | NA |
NA, not applicable.